Evofem Biosciences (EVFM)
US Market

Evofem Biosciences (EVFM) Financial Statements


Evofem Biosciences Financial Overview

Evofem Biosciences's market cap is currently ―. The company's EPS TTM is $-6.215; its P/E ratio is >-0.01; Evofem Biosciences is scheduled to report earnings on August 6, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue$ 5.11M$ 2.46M$ 181.00K$ 6.37M$ 6.03M
Gross Profit$ 3.22M$ 165.00K$ -203.00K$ 4.69M$ 4.75M
EBIT$ -3.55M$ -7.48M$ -9.98M$ 89.47M$ -24.42M
EBITDA$ -3.52M$ -7.31M$ -9.73M-$ -24.17M
Net Income Common Stockholders$ 66.00M$ -8.56M$ -11.48M$ 89.51M$ -124.07M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 636.00K$ 3.98M$ 9.04M$ 19.89M
Total Assets$ 13.32M$ 14.07M$ 25.16M$ 42.28M$ 53.47M
Total Debt$ 41.23M$ 43.20M$ 5.44M$ 6.22M$ 125.74M
Net Debt$ 41.23M$ 42.56M$ 1.47M$ -2.82M$ 105.85M
Total Liabilities$ 67.88M$ 69.74M$ 96.96M$ -35.24M$ 269.47M
Stockholders Equity$ -56.36M$ -55.66M$ -71.80M$ -78.04M$ -216.00M
Cash Flow-
Free Cash Flow$ -2.36M$ -1.50M$ -6.57M$ -16.37M$ -26.83M
Operating Cash Flow$ -2.36M$ -1.49M$ -6.53M$ -16.30M$ -26.66M
Investing Cash Flow-$ -1.00K$ -35.00K$ -70.00K$ -170.00K
Financing Cash Flow$ 2.14M$ 597.00K$ 1.50M$ 3.95M$ 41.36M
Currency in USD

Evofem Biosciences Earnings and Revenue History

Evofem Biosciences Debt to Assets

Evofem Biosciences Cash Flow

Evofem Biosciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis